These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12032180)

  • 41. New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
    Nakai K; Komaba H; Fukagawa M
    J Nephrol; 2010; 23(6):619-25. PubMed ID: 20658451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypophosphatemia and calcium nephrolithiasis.
    Prié D; Beck L; Silve C; Friedlander G
    Nephron Exp Nephrol; 2004; 98(2):e50-4. PubMed ID: 15499207
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 1,25-Dihydroxyvitamin D(3) and extracellular inorganic phosphate activate mitogen-activated protein kinase pathway through fibroblast growth factor 23 contributing to hypertrophy and mineralization in osteoarthritic chondrocytes.
    Orfanidou T; Malizos KN; Varitimidis S; Tsezou A
    Exp Biol Med (Maywood); 2012 Mar; 237(3):241-53. PubMed ID: 22393163
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Significance of FGF23 measurement].
    Fukumoto S
    Clin Calcium; 2012 Oct; 22(10):1525-9. PubMed ID: 23023632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional analysis of mutant FAM20C in Raine syndrome with FGF23-related hypophosphatemia.
    Kinoshita Y; Hori M; Taguchi M; Fukumoto S
    Bone; 2014 Oct; 67():145-51. PubMed ID: 25026495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Disorders of phosphate metabolism].
    Fukumoto S
    Rinsho Byori; 2010 Mar; 58(3):225-31. PubMed ID: 20408440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study.
    Schouten BJ; Hunt PJ; Livesey JH; Frampton CM; Soule SG
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2332-7. PubMed ID: 19366850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Klotho/FGF23 Axis in CKD.
    Tsuchiya K; Nagano N; Nitta K
    Contrib Nephrol; 2015; 185():56-65. PubMed ID: 26023015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pathogenesis of hypophosphatemia].
    Takeuchi Y
    Clin Calcium; 2016 Feb; 26(2):199-205. PubMed ID: 26813499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phosphatonin--a new phosphaturetic hormone? (lessons from tumour-induced osteomalacia and X-linked hypophosphataemia).
    Kumar R
    Nephrol Dial Transplant; 1997 Jan; 12(1):11-3. PubMed ID: 9027763
    [No Abstract]   [Full Text] [Related]  

  • 51. RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia.
    Bahrami A; Weiss SW; Montgomery E; Horvai AE; Jin L; Inwards CY; Folpe AL
    Am J Surg Pathol; 2009 Sep; 33(9):1348-54. PubMed ID: 19609206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association Between Iron-Deficiency Anemia and Hypophosphatemia.
    Kommalapati A; Singhi R; Tella SH
    Am J Med; 2018 Mar; 131(3):e103-e104. PubMed ID: 29031590
    [No Abstract]   [Full Text] [Related]  

  • 53. The importance of klotho in phosphate metabolism and kidney disease.
    Tan SJ; Smith ER; Hewitson TD; Holt SG; Toussaint ND
    Nephrology (Carlton); 2014 Aug; 19(8):439-49. PubMed ID: 24750549
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The FGF23/KLOTHO Regulatory Network and Its Roles in Human Disorders.
    Kinoshita S; Kawai M
    Vitam Horm; 2016; 101():151-74. PubMed ID: 27125741
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical aspect of recent progress in phosphate metabolism. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23)].
    Endo I
    Clin Calcium; 2009 Jun; 19(6):815-20. PubMed ID: 19483276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Fibroblast growth factor 23, a new phosphaturic factor in hypophosphatemic rickets/osteomalacia].
    Nishizawa Y; Imanishi Y
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():469-74. PubMed ID: 16279684
    [No Abstract]   [Full Text] [Related]  

  • 57. The role of bone in phosphate metabolism.
    Fukumoto S
    Mol Cell Endocrinol; 2009 Oct; 310(1-2):63-70. PubMed ID: 18822343
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Chronic kidney disease (CKD) and bone. Regulation of calcium and phosphate metabolism by FGF23/Klotho].
    Fukumoto S
    Clin Calcium; 2009 Apr; 19(4):523-8. PubMed ID: 19329831
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impairment of spatial learning and memory in transgenic mice overexpressing human fibroblast growth factor-23.
    Liu P; Chen L; Bai X; Karaplis A; Miao D; Gu N
    Brain Res; 2011 Sep; 1412():9-17. PubMed ID: 21824606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibroblast Growth Factor 23-Mediated Bone Disease.
    Gonciulea AR; Jan De Beur SM
    Endocrinol Metab Clin North Am; 2017 Mar; 46(1):19-39. PubMed ID: 28131132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.